Hisse Senetlerindeki Sıralama
#24478
AB Science S.A. is a pharmaceutical company dedicated to the discovery,... AB Science S.A. is a pharmaceutical company dedicated to the discovery, development, and commercialization of protein kinase inhibitors for applications in both human and animal health. Its primary drug candidate, masitinib, a tyrosine kinase inhibitor, is currently undergoing late-stage (Phase III) clinical investigations for a range of serious conditions including prostate cancer, pancreatic cancer, amyotrophic lateral sclerosis (ALS), multiple sclerosis, Alzheimer's disease, severe asthma, and mastocytosis. Additionally, masitinib is being evaluated in Phase II clinical trials for the treatment of Covid-19. The company's pipeline also features AB8939, a synthetic microtubule destabilizer aimed at treating acute myeloid leukemia, and AB20001, which is in Phase 2 trials to assess the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients experiencing moderate to severe COVID-19. Masitinib is sold under the brand name Masivet in the European market. AB Science S.A. was founded in 2001 and is based in Paris, France.
Ticaret AB Science S.A. (AB)
B piyasa değeri ile AB fiyatı
Piyasa Değeri AB Science S.A.(AB)
Piyasa Değeri: $60.21M
August 2026 itibarıyla AB Science S.A. şirketinin piyasa değeri $60.21M. Bu, verilerimize göre AB Science S.A. şirketini dünyanın en değerli 24478th. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
AB Science S.A. piyasa değeri geçmişi (2010 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında AB
| AB’in Fiyatı |
|
B Varlığı |
B’nin Piyasa Değeri |
Sonuçlar |
|
|
|
|
$5.210T
|
+8,652,977.79%
|
|
|
|
|
$4.535T
|
+7,530,721.37%
|
|
|
|
|
$4.148T
|
+6,888,482.82%
|
|
|
|
|
$3.579T
|
+5,943,751.82%
|
|
|
|
|
$2.779T
|
+4,614,587.01%
|
